Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)
Sponsor: Addario Lung Cancer Medical Institute
Terminated
Enrollment futility
Other terminated trials from Addario Lung Cancer Medical Institute
See all terminations from Addario Lung Cancer Medical Institute
Other Non Small Cell Lung Cancer trials with similar outcome
Listed as NCT03553550, this observational or N/A phase trial focuses on Non Small Cell Lung Cancer and remains terminated or withdrawn. Sponsored by Addario Lung Cancer Medical Institute, it has been updated 14 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
▶ Show 9 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Terminated
Status: Recruiting → Terminated
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2020 — Oct 2020 [monthly]
Recruiting
-
Nov 2019 — Feb 2020 [monthly]
Recruiting
-
Sep 2019 — Nov 2019 [monthly]
Recruiting
-
Apr 2019 — Sep 2019 [monthly]
Recruiting
-
Aug 2018 — Apr 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Not Yet Recruiting
First recorded
Jun 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Addario Lung Cancer Medical Institute
For direct contact, visit the study record on ClinicalTrials.gov .